Information Provided By:
Fly News Breaks for November 12, 2015
EW
Nov 12, 2015 | 06:32 EDT
Citi analyst Amit Hazan started shares of Edwards Lifesciences with a Sell rating and $134 price target. The analyst is below consensus expectations for the overall TAVR market and views shares as overvalued at current levels.
News For EW From the Last 2 Days
There are no results for your query EW